Malignant lymphoma in cyclosporin A treated allograft recipients.
D000818:Animals; D006084:Graft Rejection / Q000187:drug effects; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008223:Lymphoma / Q000139:chemically induced / Q000209:etiology*; D010456:Peptides, Cyclic / Q000009:adverse effects*; D012306:Risk; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D010456:Peptides, Cyclic